Bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia: Results from the randomized BFORE trial

Jorge E. Cortes, Carlo Gambacorti-Passerini, M. W. Deininger, Michael J. Mauro, Charles Chuah, Dong Wook Kim, Irina Dyagil, Nataliia Glushko, Dragana Milojkovic, P. Le Coutre, Valentin Garcia-Gutierrez, Laurence Reilly, Allison Jeynes-Ellis, Eric Leip, Nathalie Bardy-Bouxin, Andreas Hochhaus, Tim H. Brümmendorf

Research output: Contribution to journalArticlepeer-review

123 Scopus citations

Fingerprint Dive into the research topics of 'Bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia: Results from the randomized BFORE trial'. Together they form a unique fingerprint.

Medicine & Life Sciences